BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li SM, Yao SK, Yamamura N, Nakamura T. Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia. World J Gastroenterol 2003; 9(11): 2579-2582 [PMID: 14606101 DOI: 10.3748/wjg.v9.i11.2579]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2579.htm
Number Citing Articles
1
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 587 doi: 10.1007/978-3-319-26956-6_30
2
Md. Emranul Karim, Kyi Kyi Tha, Iekhsan Othman, Mohammad Borhan Uddin, Ezharul Hoque Chowdhury. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of CancersPharmaceutics 2018; 10(2): 65 doi: 10.3390/pharmaceutics10020065
3
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_30-1
4
Marc-Oliver Riener, Alexander Vogetseder, Bernhard C. Pestalozzi, Pierre-Alain Clavien, Nicole Probst-Hensch, Glen Kristiansen, Wolfram Jochum. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tractHuman Pathology 2010; 41(11): 1558 doi: 10.1016/j.humpath.2009.12.016
5
Zhi-Ming Li, Zong-Chao Liu, Zhong-Zhen Guan, Xiao-Feng Zhu, Jun-Min Zhou, Bing-Fen Xie, Gong-Kan Feng, Zhen-Yu Zhu, Wen-Qi Jiang. Inhibition of DNA primase and induction of apoptosis by 3,3’-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cellsWorld Journal of Gastroenterology 2004; 10(4): 514-520 doi: 10.3748/wjg.v10.i4.514